Drug Patent Watch
JUNE 23, 2022
This chart shows the pharmaceutical companies with the most patents in Slovakia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Slovakia? appeared first on DrugPatentWatch - Make Better Decisions.
Drug Channels
JUNE 21, 2022
National Association of Specialty Pharmacy (NASP) 2022 Annual Meeting & Expo. September 19-22, 2022 | Gaylord Palms Resort & Convention Center | Orlando, FL. www.naspnet.org/annualmeeting. The National Association of Specialty Pharmacy (NASP) will host the NASP 2022 Annual Meeting & Expo September 19-22. NASP will celebrate their 10th Anniversary and welcome attendees to a new conference venue – the gorgeous Gaylord Palms Resort & Convention Center, located in Orlando, Florida.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Manufacturing
JUNE 24, 2022
Pharma can do better than 50% compliance
The Open Targets Blog
JUNE 24, 2022
The latest release of the Platform — 22.06 — is now available at platform.opentargets.org. Key points We have included five additional studies in our Gene Burden widget, incorporating evidence from a number of different therapeutic areas The term “ medical procedure ” has been added to our ontology Users can now visualise subcellular locations of targets Key stats Metric Count Targets 61,524 Diseases 23,074 Drugs 12,854 Evidence strings 14,455,104 Associations 7,247,8
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Drug Patent Watch
JUNE 18, 2022
Annual Drug Patent Expirations for GLEEVEC Gleevec is a drug marketed by Novartis and is included in two NDAs. It is available from one supplier. There is one patent protecting…. The post New patent expiration for Novartis drug GLEEVEC appeared first on DrugPatentWatch - Make Better Decisions.
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
Crown Bioscience
JUNE 22, 2022
Do you ever wonder how tumor organoids and ex vivo microtumors (i.e., patient tumor material) are being used in immuno-oncology (I/O)?
EG Life Sciences
JUNE 22, 2022
The pharmaceutical industry is one of the most highly regulated industries, and for good reason. These organizations are tasked with protecting the rights and well-being of subjects, along with the integrity of data and analysis. As a result, audits are a crucial part of our business.
Drug Patent Watch
JUNE 24, 2022
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Italy. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…. The post Which pharmaceutical companies have the most SPCs in Italy? appeared first on DrugPatentWatch - Make Better Decisions.
Drug Channels
JUNE 22, 2022
Recently, I explored the complex web of relationships and conflicts that support today’s discount card economics. See The GoodRx-Kroger Blowup: Spread Pricing, Pharmacy Margins, and the Future of Discount Cards. In the video below, I discuss how generic drug pricing and the rise of patient-paid, discount card prescriptions pose a risk to pharmacy benefit plans and the PBM business.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
The Open Targets Blog
JUNE 21, 2022
My name is Carlos Cruz. I'm a software engineer focused on front end. As part of the Open Targets team, I work on maintaining and developing the Open Targets web applications. At Open Targets, we maintain two UI applications: the Open Targets Platform and Open Targets Genetics. Both are JavaScript applications that use React , GraphQL , and MUI , among other libraries.
Advarra
JUNE 21, 2022
Establishing a compliant pharmacovigilance (PV) function from scratch is often an overwhelming exercise for emerging biotech organizations, typically competing with the priorities of bringing a new drug to market. However, asking the right questions before starting the journey can mitigate the risks of PV findings and ensure a successful PV function build for the organization.
Drug Patent Watch
JUNE 24, 2022
Annual Drug Patent Expirations for ELESTRIN Elestrin is a drug marketed by Mylan Speciality Lp and is included in one NDA. It is available from one supplier. There is one…. The post New patent expiration for Mylan Speciality drug ELESTRIN appeared first on DrugPatentWatch - Make Better Decisions.
Creative Biolabs
JUNE 20, 2022
In a new study, researchers from Emory University revealed that cancer-causing mutations result in widespread distortions in protein-protein interaction networks in cells. The findings were recently published online in the journal Cell. “A mutation that causes cancer is an altered protein-protein interaction network. The mutation may form a new epitope—a new interaction surface,” said Dr.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
The Pharma Data
JUNE 19, 2022
Most skin cancer drugs that activate the immune system work by triggering immune cells, called T cells, to attack tumors, but when T cells are activated for too long, they can wear out and cease to function. A new study led by Penn State College of Medicine scientists finds that another type of immune cell – natural killer cells – can be harnessed to pick up the slack when T cells no longer work and may also reinvigorate T cells to attack melanoma tumors.
Pharma Manufacturing
JUNE 21, 2022
Did short-term solutions for COVID-19 stifle long-term mRNA success?
Drug Patent Watch
JUNE 24, 2022
Annual Drug Patent Expirations for GELNIQUE+3%25 Gelnique 3% is a drug marketed by Allergan and is included in one NDA. There is one patent protecting this drug. Drug patent litigation…. The post New patent expiration for Allergan drug GELNIQUE 3% appeared first on DrugPatentWatch - Make Better Decisions.
Nvidia Developer: Drug Discovery
JUNE 24, 2022
The field of drug discovery is at a fascinating inflection point. The physics of the problem are understood and calculable, yet quantum mechanical calculations. The field of drug discovery is at a fascinating inflection point. The physics of the problem are understood and calculable, yet quantum mechanical calculations are far too expensive and time consuming.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Drug & Device Law
JUNE 24, 2022
Summary judgment was affirmed in Vesoulis v. ReShape LifeSciences, Inc. , 2022 WL 989465 (5th Cir. April 1, 2022), although the recent troubling trend towards non-precedential defense wins but precedential defense losses continues. Vesoulis was a one-off suit under Louisiana law against the manufacturer of a pre-market (“PMA”)-approved medical device and the implanting – or, more properly, explanting – surgeon.
Pharma Manufacturing
JUNE 20, 2022
Advanced automation can speed the validation process, helping pharma projects come online faster
Drug Patent Watch
JUNE 24, 2022
Annual Drug Patent Expirations for PEPAXTO Pepaxto is a drug marketed by Oncopeptides Ab and is included in one NDA. There are five patents protecting this drug. This drug has…. The post New patent expiration for Oncopeptides Ab drug PEPAXTO appeared first on DrugPatentWatch - Make Better Decisions.
Drug Patent Watch
JUNE 24, 2022
Annual Drug Patent Expirations for APTIOM Aptiom is a drug marketed by Sunovion Pharms Inc and is included in one NDA. It is available from one supplier. There are ten…. The post New patent for Sunovion Pharms drug APTIOM appeared first on DrugPatentWatch - Make Better Decisions.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Drug Patent Watch
JUNE 24, 2022
Annual Drug Patent Expirations for TIBSOVO Tibsovo is a drug marketed by Servier and is included in one NDA. There are eight patents protecting this drug. This drug has one…. The post New patent for Servier drug TIBSOVO appeared first on DrugPatentWatch - Make Better Decisions.
Drug Patent Watch
JUNE 24, 2022
Annual Drug Patent Expirations for ABILIFY+MAINTENA+KIT Abilify Maintena Kit is a drug marketed by Otsuka Pharm Co Ltd and is included in one NDA. It is available from one supplier.…. The post New patent for Otsuka Pharm drug ABILIFY MAINTENA KIT appeared first on DrugPatentWatch - Make Better Decisions.
Drug Patent Watch
JUNE 23, 2022
Annual Drug Patent Expirations for GATTEX+KIT Gattex Kit is a drug marketed by Takeda Pharms Usa and is included in one NDA. It is available from one supplier. There are…. The post New patent for Takeda Pharms drug GATTEX KIT appeared first on DrugPatentWatch - Make Better Decisions.
Drug Patent Watch
JUNE 22, 2022
This chart shows the pharmaceutical companies with the most patents in Luxembourg. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Luxembourg? appeared first on DrugPatentWatch - Make Better Decisions.
Drug Patent Watch
JUNE 22, 2022
Annual Drug Patent Expirations for ZEMBRACE+SYMTOUCH Zembrace Symtouch is a drug marketed by Upsher Smith Labs and is included in one NDA. It is available from two suppliers. There is…. The post New patent for Upsher Smith drug ZEMBRACE SYMTOUCH appeared first on DrugPatentWatch - Make Better Decisions.
Expert insights. Personalized for you.
98 
Let's personalize your content